Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. (+)-ephedrine
2. L-(+)-ephedrine
3. Racephedrine
4. 321-98-2
5. 90-81-3
6. Ephedrine, (+)-
7. (1s,2r)-ephedrine
8. (1s,2r)-2-(methylamino)-1-phenylpropan-1-ol
9. 03vry66076
10. 72087nsy56
11. ( Inverted Exclamation Marka)-ephedrine
12. (+)-ephedrin
13. (+)-(1s,2r)-ephedrine
14. Ephedrine Dl-form
15. (+)-ephedrine Anhydrous
16. Benzenemethanol, .alpha.-[(1r)-1-(methylamino)ethyl]-, (.alpha.s)-rel-
17. 2-methylamino-1-phenylpropan-1-ol
18. (+-)-ephedrine
19. (1r,2s)-(-)-ephedrine
20. Einecs 206-293-3
21. Racephedrine [inn:ban]
22. Brn 4231286
23. Unii-03vry66076
24. Unii-72087nsy56
25. .psi.-ephedrine
26. .psi.-ephedrin
27. Benzenemethanol, .alpha.-((1r)-1-(methylamino)ethyl)-, (.alpha.s)-rel-
28. Einecs 202-017-0
29. D-.psi.-ephedrine
30. D-(-)-ephedrine
31. (+/-)-ephedrine
32. Novafed (salt/mix)
33. Sinufed (salt/mix)
34. Brn 3197916
35. Tussaphed (salt/mix)
36. (+)-erythro-ephedrine
37. Ephedrine, D-(-)-
38. Symptom 2 (salt/mix)
39. Benzenemethanol, Alpha-((1r)-1-(methylamino)ethyl)-, (alphas)-
40. Benzenemethanol, Alpha-(1-(methylamino)ethyl)-, (s-(r*,s*))-
41. L(+)-.psi.-ephedrine
42. Racephedrine [inn]
43. .psi.-ephedrine, (+)-
44. (1s,2r)-(-)-ephedrine
45. 4-13-00-01881 (beilstein Handbook Reference)
46. Racephedrine [who-dd]
47. Schembl420779
48. Ephedrine, (+-)-
49. Benzenemethanol, .alpha.-[1-(methylamino)ethyl]-, [s-(r*,r*)]-
50. Ephedrine Dl-form [mi]
51. Chembl2110656
52. Niosh/kb0650000
53. Hy-b0980a
54. Zinc74840
55. Alpha-(1-(methylaminoethyl)benzenemethanol, (s-(r*,s*)-
56. Dtxsid20891194
57. Dtxsid60889333
58. Benzenemethanol, .alpha.-[(1r)-1-(methylamino)ethyl]-, (.alpha.s)-
59. Pdsp1_001345
60. Pdsp2_001329
61. Pdsp2_001331
62. Akos027326694
63. Cs-4471
64. Kb06500000
65. 2-(methylamino)-1-phenyl-1-propanol, D-.psi.- #
66. Q22330463
67. (r*,s*)-(+-)-alpha-(1-(methylamino)ethyl)benzyl Alcohol
68. [s-(r*,r*)]-.alpha.-[1-(methylamino)ethyl]benzenemethanol
69. .alpha.-((1s)-1-(methylamino)ethyl)benzyl Alcohol, (.alpha.s)-
70. .alpha.-[(1s)-1-(methylamino)ethyl]benzenemethanol, (.alpha.s)-
71. Benzenemethanol, Alpha-(1-(methylamino)ethyl)-, (r*,s*)-(+-)-
72. Benzenemethanol, .alpha.-(1-(methylamino)ethyl)-, (s-(r*,s*))-
73. Benzenemethanol, Alpha-((1r)-1-(methylamino)ethyl)-, (alphas)-rel-
74. Benzenemethanol, .alpha.-(1-(methylamino)ethyl)-, (r*,s*)-(+/-)-
| Molecular Weight | 165.23 g/mol |
|---|---|
| Molecular Formula | C10H15NO |
| XLogP3 | 0.9 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 3 |
| Exact Mass | 165.115364102 g/mol |
| Monoisotopic Mass | 165.115364102 g/mol |
| Topological Polar Surface Area | 32.3 Ų |
| Heavy Atom Count | 12 |
| Formal Charge | 0 |
| Complexity | 121 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Digital Content 
NEWS #PharmaBuzz
Global Sales Information
ABOUT THIS PAGE
51
PharmaCompass offers a list of Racephedrine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Racephedrine manufacturer or Racephedrine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Racephedrine manufacturer or Racephedrine supplier.
PharmaCompass also assists you with knowing the Racephedrine API Price utilized in the formulation of products. Racephedrine API Price is not always fixed or binding as the Racephedrine Price is obtained through a variety of data sources. The Racephedrine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A (+)-Ephedrine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of (+)-Ephedrine, including repackagers and relabelers. The FDA regulates (+)-Ephedrine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. (+)-Ephedrine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A (+)-Ephedrine supplier is an individual or a company that provides (+)-Ephedrine active pharmaceutical ingredient (API) or (+)-Ephedrine finished formulations upon request. The (+)-Ephedrine suppliers may include (+)-Ephedrine API manufacturers, exporters, distributors and traders.
(+)-Ephedrine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of (+)-Ephedrine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right (+)-Ephedrine GMP manufacturer or (+)-Ephedrine GMP API supplier for your needs.
A (+)-Ephedrine CoA (Certificate of Analysis) is a formal document that attests to (+)-Ephedrine's compliance with (+)-Ephedrine specifications and serves as a tool for batch-level quality control.
(+)-Ephedrine CoA mostly includes findings from lab analyses of a specific batch. For each (+)-Ephedrine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
(+)-Ephedrine may be tested according to a variety of international standards, such as European Pharmacopoeia ((+)-Ephedrine EP), (+)-Ephedrine JP (Japanese Pharmacopeia) and the US Pharmacopoeia ((+)-Ephedrine USP).
